Abstract:
The present invention relates to a composition for preventing or treating colon cancer, containing 3,6-anhydro-L-galactose, and more specifically, provides excellent anti-cancer effects by inducing apoptosis of colon cancer cells and inhibiting the growth of colon cancer cells by using 3,6-anhydro-L-galactose separated from red algae-derived agar and purified.
Abstract:
The present invention relates to agarooligosaccharide hydrolase and a method for producing 3,6-anhydro-L-galactose and galactose from agarose by using the same. More specifically, the production yield of 3,6-anhydro-L-galactose and galactose from agarose, that is, the saccharification yield, is improved by using β-agarooligosaccharide hydrolase having an agarotriose hydrolytic activity.
Abstract:
The present invention provides Hahella chejuensis-derived recombinant cellulase and a use thereof. The recombinant cellulase according to the present invention has a high stability at a high temperature and an optimized activity at a neutral pH, and therefore has a high availability in a process. Also, since the cellulase according to the present invention has an exoglucanase activity as well as an endoglucanase activity, a monosaccharide can be produced during decomposition of cellulose and an additional treatment required in a fermentation process is not needed, and therefore a cost may be reduced. Such an enzyme activity is advantageous to a fermentation or thermal treatment condition for producing a biofuel, and therefore industrial profits may be achieved.